|
|
|
03.04.26 - 09:01
|
ASML und RWE: Green-Chip-Allianz sichert Strom bis 2038 (Der Aktionaer)
|
|
|
Der Energiehunger der Halbleiterindustrie wird zum strategischen Risiko, doch ASML sichert nun die Produktion der nächsten Chip-Generation ab. Gemeinsam mit dem Energieversorger RWE erweiterten die Niederländer am gestrigen Donnerstag ihre Kooperation, um die Werke in Veldhoven langfristig mit grünem Strom aus der Nordsee zu versorgen....
|
|
|
02.04.26 - 20:24
|
Target RWE Strengthens Leadership Team with Appointments Across Delivery, Finance and Commercial (Business Wire)
|
|
|
Appointments reinforce operational excellence and strategic growth to advance evidence generation and clinical trialsDURHAM, N.C.--(BUSINESS WIRE)--Target RWE, a leader in advancing modern evidence generation for complex clinical and regulatory challenges, today announced key updates to its leadership team, including the promotion of Steve Swanson to chief commercial officer, alongside the appointments of Emily Akin as head of delivery and Ashley Pierce as head of finance. These leadership updates position the company to scale operations, accelerate growth, and further the delivery of our clinical evidence generation solutions, including real-world data and clinical trials.
Now chief commercial officer, Swanson leads the company's commercial strategy, including business development, partnerships, and go-to-market execution. In this role, he is committed to building deeper, more strategic relationships with biopharma and healthcare partners to drive stronger collaboration and improve outcomes for clients,...
|
|
|
|
|
02.04.26 - 09:48
|
Aktienanleihe auf RWE: 12,2% Renditechance im Fokus - Anleiheanalyse (Anleihencheck)
|
|
|
Gablitz (www.anleihencheck.de) - Die Experten vom "ZertifikateReport" stellen in ihrer aktuellen Ausgabe u.a. eine Aktienanleihe (ISIN DE000HM2JRE9/ WKN HM2JRE) der HSBC auf die Aktie von RWE (ISIN DE0007037129/ WKN 703712) vor.
Mit einem milliardenschweren Investitionsprogramm und einer stärkeren Expansion in den USA wolle der Energiekonzern RWE seine Erträge in den kommenden Jahren deutlich steigern. [mehr]...
|
|
|
|
|
|
|
01.04.26 - 13:18
|
RWE Market-Perform (DPA-AFX)
|
|
|
NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für RWE auf "Market-Perform" mit einem Kursziel von 57 Euro belassen. Ähnlich wie in der Energiekrise 2022 sei die Lieferung fossiler Energieträger durch den Krieg ......
|
|
|
|
|
01.04.26 - 08:21
|
RWE Overweight (DPA-AFX)
|
|
|
NEW YORK (dpa-AFX Analyser) - JPMorgan hat das Kursziel für RWE von 57 auf 65 Euro angehoben und die Einstufung auf "Overweight" belassen. Die Aktie steht zudem auf der "Analyst Focus List" der US-Bank. Javier Garrido sieht die europäischen Versorger ......
|
|
|
|
|
|
|
|
|
|
|
27.03.26 - 10:42
|
RWE Buy (DPA-AFX)
|
|
|
FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat das Kursziel für RWE von 55 auf 63 Euro angehoben und die Einstufung auf "Buy" belassen. Analyst Olly Jeffery sieht die Aktien des Energiekonzerns in seinem am Freitag vorliegenden Report als ......
|
|
|
|
|
|
|
26.03.26 - 16:07
|
Fossil fuel companies finally accept the climate crisis – just not their role in it (The Guardian)
|
|
|
The era of corporate climate denial is over but in courts around the world the big names have shifted strategyWhile the US government continues to call climate change a hoax and attack the science, in courtrooms from The Hague to Honolulu, fossil fuel companies are taking a different approach. Shell, Chevron, RWE and TotalEnergies all accept that climate change is real, human-caused and serious. The era of corporate climate denial, at least in legal proceedings, is largely over.What has replaced it is a more nuanced position: accepting the science of climate change while contesting their responsibility for it. Continue reading......
|
|
|
|
|
26.03.26 - 08:18
|
RWE Market-Perform (DPA-AFX)
|
|
|
NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat das Kursziel für RWE von 55 auf 57 Euro angehoben, aber die Einstufung auf "Market-Perform" belassen. Analystin Deepa Venkateswaran aktualisierte nach den vorgelegten Jahreszahlen ......
|
|
|
26.03.26 - 07:30
|
Double Bond Pharmaceutical Collaborates with Karolinska Institutet in Stockholm for Advanced RWE Analysis of Temodex (Cision)
|
|
|
Uppsala, Sweden – March 26, 2026 – Double Bond Pharmaceutical AB (publ) (“DBP”) announces its participation in the Karolinska Institutet (KI) Career Service Internship Program. Through this initiative, DBP will host a PhD student or Postdoctoral researcher from KI to collaborate on the advanced analysis of Real-World Evidence (RWE) for Temodex, the company's innovative treatment for glioblastoma.
Strengthening Data Precision for Temodex
The KI program is designed to bridge the gap between high-level academic research and industrial application. For DBP, this collaboration...
|
|